Can you talk about that a little?

Right.

You know, again, different cancers are different, and PD-L1 is an indication that probably that immune therapy is likely to be helpful to you.

But many patients, not enough, and therefore they give it with chemotherapy.

If your cancer looks very aggressive, they may well say, let's start having some chemotherapy.

We could maybe drop that off later.

And PD-L1 goes from 0 to 100.

So I think I know the answer to this, but can you just share how knowing your own PD-L1, knowing your biomarkers has helped you be a contributor to your own care plan?

So I would be curious to hear from you as a patient that's gone through kind of every bit of this spectrum How do you feel about the introduction of AI into healthcare or this kind of cancer detection space?

Well, you know, I am a... believe it or not, a really early advocate of AI.

In the 70s, I did a master's thesis in computer science, and my topic was an AI topic, which people don't realize that there was AI back even in the 50s with Turing.

I was just going to say, I think one thing that AI can do is just help... make patients aware, remind people to get them scheduled.

I think some patients and a lot of patients are actually concerned that that will depersonalize things.

But in some ways, some of these new AI chatbots are even more personal and some people recognize that.

The jury's still out, there's pros and cons, and certainly there's probably using AI to analyze mammograms is one of the furthest along.

it's gone anyway, right? It's one of the